Table 3 Comparison of Outcomes of all patients in our study
Total (n = 480) | RBP > 20.95 mg/L (n = 368) | RBP ≤ 20.95 mg/L (n = 112) | P-value | |
|---|---|---|---|---|
Primary outcomes | ||||
3-month mortality | 12 (2.5%) | 5 (1.4%) | 7 (6.3%) | 0.011 |
6-month mortality | 22 (4.6%) | 12 (3.3%) | 10 (8.9%) | 0.012 |
1-year mortality | 69 (14.4%) | 42 (11.4%) | 27 (24.1%) | 0.001 |
Secondary outcomes | ||||
3-month independent walking rate | 113 (23.5%) | 96 (26.1%) | 17 (15.2%) | 0.017 |
6-month independent walking rate | 274 (57.1%) | 223 (60.6%) | 51 (45.5%) | 0.005 |
1-year independent walking rate | 339 (70.6%) | 270 (73.4%) | 69 (61.6%) | 0.017 |
Hospital stays (days) | 15.83 ± 7.37 | 16.01 ± 7.79 | 15.25 ± 5.80 | 0.502 |
Hospitalization costs (CNY) | 78,493.20 ± 24,466.96 | 78,513.18 ± 24,526.43 | 78,427.53 ± 24,380.03 | 0.884 |